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Propeptides of the vitamin K-dependent proteins bind
to an exosite on -glutamyl carboxylase; while they are
bound, multiple glutamic acids in the -carboxyglu-
tamic acid (Gla) domain are carboxylated. The role of
the propeptides has been studied extensively; however,
the role of the Gla domain in substrate binding is less
well understood. We used kinetic and fluorescence tech-
niques to investigate the interactions of the carboxylase
with a substrate containing the propeptide and Gla do-
main of factor IX (FIXproGla41). In addition, we charac-
terized the effect of the Gla domain and carboxylation
on propeptide and substrate binding. For the propep-
tide of factor IX (proFIX18), FIXproGla41, and carboxy-
lated FIXproGla41, the Kd values were 50, 2.5, and 19.7
nM and the koff values were 273  10
5, 9  105, and 37 
105 s1, respectively. The koff of proFIX18 is reduced
3-fold by FLEEL and 9-fold by the Gla domain (residues
1–46) of FIX. The pre-steady state rate constants for
carboxylation of FIXproGla41 was 0.02 s1 in enzyme
excess and 0.016 s1 in substrate excess. The steady state
rate in substrate excess is 4.5  104 s1. These results
demonstrate the following. 1) The pre-steady state car-
boxylation rate constant of FIXproGla41 is significantly
slower than that of FLEEL. 2) The Gla domain plays an
allosteric role in substrate-enzyme interactions. 3) Car-
boxylation reduces the allosteric effect. 4) The similarity
between the steady state carboxylation rate constant
and product dissociation rate constant suggests that
product release is rate-limiting. 5) The increased disso-
ciation rate after carboxylation contributes to the re-
lease of product.
The vitamin K-dependent -glutamyl carboxylase is an inte-
gral membrane protein located in the endoplasmic reticulum. It
catalyzes the post-translational modification of specific glu-
tamic acid residues to -carboxylglutamic acid in a number of
vitamin K-dependent proteins. In these vitamin K-dependent
proteins, multiple glutamic acid residues in the amino-termi-
nal Gla1 domain are modified (1–3). The existence of these
multiple -carboxylglutamic acid residues allows the Gla do-
main to form the calcium-dependent conformation required for
the activity of these vitamin K-dependent proteins (4, 5). Un-
der-carboxylated vitamin K-dependent proteins cannot form
this calcium-dependent structure and, as a result, possess poor
affinities for phospholipid surfaces, endothelial cells, or acti-
vated platelets (6–8).
Previous studies indicate that all or nearly all of the Glu
residues to be carboxylated are modified during a single sub-
strate binding event (9, 10). The loss of as few as three car-
boxylations can markedly decrease the activities of vitamin
K-dependent proteins (8). Therefore, because the most fre-
quently used anticoagulant, warfarin, causes under-carboxyla-
tion by reducing vitamin K concentration, understanding the
mechanism by which processivity yields functional enzymes
is important.
A tethered model has been proposed to account for how
carboxylase accomplishes full carboxylation of pro-factor IX (9,
11). In this hypothesis, the primary interaction between car-
boxylase and its substrates is mediated by a propeptide se-
quence of 18 amino acids. Presumably, the propeptide anchors
the Gla domain of the substrate near the carboxylase active site
for a time sufficient for modification of all or most of the Glu
residues of the Gla domain.
Several lines of evidence are consistent with the idea that
full carboxylation is the result of a stochastic, processive mech-
anism, i.e. the degree of carboxylation is controlled by the
balance between the carboxylation rate of the substrate and the
dissociation rate of the product. First, bone Gla protein, whose
propeptide has an extremely low affinity (Ki  500 M) for the
carboxylase and therefore a rapid dissociation rate (12, 13), is
routinely under-carboxylated in the general population. How-
ever, diets supplemented with vitamin K, which should in-
crease the rate of carboxylation, resulted in full carboxylation
of bone Gla protein in the individuals studied (14, 15). Second,
individuals with mutations in the FIX propeptide (A–10T,
A–10V, and N–9K) were identified because warfarin therapy
affected the activity of factor IX much more than expected (16,
17). These mutations also reduce the affinity of the propeptide
for the carboxylase 10–600-fold. The extent of the warfarin
effect correlates with both the affinity of the mutant propeptide
for the carboxylase and the concentration of vitamin K. Finally,
about 70% of factor X is uncarboxylated when expressed in cell
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culture. The propeptide of factor X binds tighter to the carbox-
ylase than the propeptide of any other coagulation protein.
Thus, when factor X was overexpressed in cell culture (sub-
strate excess), we predicted that product release would be
rate-limiting, and a large fraction of the factor X would be
secreted having by-passed the carboxylase. We predicted that
changing the propeptide to one with lower affinity (but not so
low as to lead to premature dissociation) would increase the
turnover rate and result in increased carboxylation. This pre-
diction was realized as decreasing the affinity of the propeptide
from 2.6 to 277 nM resulted in the percentage of fully car-
boxylated factor X increasing from about 32% to about 85%
(18). All these examples can be explained by a balance between
the rate of carboxylation and the rate of product dissociation,
i.e. either reducing the rate of carboxylation or increasing the
rate of dissociation would lead to increased amounts of under-
carboxylated clotting proteins.
In contrast to the clear role of the propeptide in carboxyla-
tion, the contribution of the Gla domain to binding has not been
well defined. Price et al. (19) proposed that a conserved se-
quence within the Gla domains of vitamin K-dependent pro-
teins E(XC)XX(EREXC) is important for substrate-carboxylase
interaction. In a typical Gla domain, the two cysteines in this
motif form a disulfide bond. In support of this hypothesis,
mutating either of the two conserved cysteines in the Gla
domain of protein C results in under-carboxylated protein C
(20). Furie et al. (21), however, report that mutation of either of
the equivalent cysteines in the Gla domain of prothrombin does
not affect carboxylation.
Both in vitro and in vivo experiments suggest that the
propeptide is sufficient for carboxylation of a Glu-containing
non-Gla domain substrate. Bovill et al. (7) made a substrate
consisting of the propeptide of prothrombin attached to a ran-
dom portion of its catalytic domain. This construct was fully
carboxylated in cell culture. We joined a random sequence
containing five glutamic acid residues to the propeptide of
factor IX, and we examined its carboxylation in vitro. Our
results indicate that the major product of the reaction was
carboxylated at least four times in a processive manner (11).
The substrate was probably fully carboxylated as it has since
been shown that Gla moieties are preferentially ejected during
mass spectrometry (22).
Although the contribution of a specific Gla domain sequence
is still in question, evidence clearly suggests that substrates
affect the binding of the propeptide of FIX to carboxylase,
increasing its affinity about 3-fold. Presnell et al. (23) propose
a working model to explain the effect of Glu residues on the
carboxylase-substrate interaction. In this model, the binding
energy necessary for full carboxylation of vitamin K-dependent
proteins is conferred by the propeptide of the substrate; the
affinity of the propeptide is in turn regulated by the occupancy
of Glu at the carboxylase active site.
We have demonstrated previously (24) that the propeptides
of the vitamin K-dependent proteins have very different affin-
ities for the carboxylase. However, the affinity for a propeptide-
containing substrate has not been reported previously. To test
the contribution of the Gla domain in the interaction of carbox-
ylase and its substrate, we have measured the affinities of the
propeptide of factor IX covalently attached to the first 41 res-
idues of the Gla domain of factor IX (FIXproGla41). Our results
show that the affinity for carboxylase increases by a factor of 20
when the propeptide is covalently attached to a Gla domain. In
addition, we measured the koff of propeptide, FIXproGla41, and
carboxylated FIXproGla41. We also measured the rate of car-
boxylation of a carboxylase-bound FIXproGla41 under condi-
tions of excess enzyme. Our studies indicate that a linkage
exists between the active site and the propeptide-binding site
and that this linkage effect may be important for the proces-
sivity of carboxylase. Furthermore, the koff of a fully carboxy-
lated substrate FIXproGla41 is about three times faster than
its non-carboxylated counterpart. This difference in dissocia-
tion rate may be significant for product release.
EXPERIMENTAL PROCEDURES
Materials
All chemicals were reagent grade. FLEEL and t-butoxycarbonyl-Glu-
t-butyl ester were purchased from Bachem (Philadelphia, PA). Peptide
FLDDL was from Chiron Mimotopes (Clayton Victoria, Australia).
CHAPS was from Pierce. Leupeptin, pepstatin, aprotinin, and phenyl-
methylsulfonyl fluoride were from Roche Applied Science. Vitamin K1
was from Sigma and was reduced to hydroquinone (KH2), as described
previously (25). 1,2-Dioleoyl-sn-glycero-3-phosphocholine was from
Avanti Polar Lipids (Alabaster, AL). Bovine serum albumin (fraction V,
heat shock) was from Roche Applied Science. Fluorescein-labeled and
unlabeled peptides, based on the human FIX propeptide, proFIX18, or
based on human pro-factor IX sequence–18-41, FIXproGla41 (and its
fully carboxylated counterpart), were chemically synthesized, purified,
and verified by ion spray mass spectrometry by Chiron Mimotopes
(Clayton Victoria, Australia) or by Genemed Synthesis (South San
Francisco, CA). For synthesis of the fluorescein-labeled propeptides,
5(6)-carboxyfluorescein was conjugated to the amino terminus of the
propeptide. All peptides were 95% pure as determined by mass spec-
trometry and high pressure liquid chromatography. Labeling of the
peptide with fluorescein was found to have no significant effect on
carboxylase-propeptide interaction (23) or on the Km and Vmax for
FIXproGla41 carboxylation (data not shown). The pSK vector was
from Stratagene (La Jolla, CA). The pVL1392 vector was from Pharm-
ingen (San Diego, CA). The BacVector 3000 baculoviral DNA was from
Novagen (Madison, WI). Sf9 insect cells were obtained from the
Lineberger Cancer Center at the University of North Carolina, Chapel
Hill. High Five insect cells were provided by Dr. Thomas Kost of Glaxo
Wellcome. HPC4 antibody affinity resin was obtained from Dr. Charles
Esmon (Oklahoma Medical Research Foundation). SP-Sepharose was
from Amersham Biosciences. All other materials were from Sigma and
were reagent grade. Carboxylase was 98% pure as described previ-
ously (24) and was titrated to determine the concentration of active
enzyme (23).
Methods
Fluorescence Anisotropy—All measurements were performed in a
400-l fluorimetric quartz cuvette (Starna Cells, Atascadero, CA) at
17 °C, with a final volume of 300 l. Before analysis, enzymes and
peptides were pre-incubated for 1 h in buffer A, containing 50 mM
MOPS (pH 7.5), 500 mM NaCl, 5% glycerol, 6.3 mM dithiothreitol, 66 M
EDTA, 0.16% 1,2-dioleoyl-sn-glycero-3-phosphocholine, 0.16% CHAPS,
and 0.2% bovine serum albumin. The excitation and emission wave-
lengths were 490 and 525 nm, respectively. Anisotropy was measured
with an OLIS modified T-format SLM spectrofluorimeter (On-Line In-
struments, Bogart, GA) essentially as described (23, 26).
Determining the Kd of ProFIX18 and of FIXproGla41 for Carboxyl-
ase—For each sample, the desired concentration of carboxylase was
pre-incubated with either 10 nM fluorescein-labeled proFIX18 (f-pro-
FIX18), 10 nM fluorescein-labeled FIXproGla41 (f-FIXproGla41), or 10
nM fluorescein-labeled carboxylated FIXproGla41 (f-carboxylated
FIXproGla41) in buffer A and at 17 °C for 1 h. No significant loss of
carboxylase activity at 17 °C was detected within 2 h in the absence of
substrate or within 24 h in the presence of saturating substrate. The
fraction of bound fluorescein-labeled peptide and the Kd values were
determined from anisotropy, as described previously (23, 26).
Kinetic Studies—For enzyme excess studies of FIXproGla41 carbox-
ylation, we pre-incubated 250 nM active carboxylase with 50 nM
FIXproGla41 in buffer A at 17 °C for 1 h. Reactions were initiated by the
addition of 120 M vitamin K hydroquinone and 10 Ci of NaH14CO3
(specific activity 55 mCi/mmol). Control experiments included 800 nM
proFIX18 added after the 1-h incubation to determine whether re-
association of any released partially carboxylated product occurred
during the reaction. At each time interval, we removed 100 l of the
sample from the 1.5-ml reaction mixture and determined the incorpo-
ration of 14CO2 as described previously (25). Backgrounds were deter-
mined from reactions that omitted FIXproGla41. Both [14C]alanine (93
mCi/mmol) and a 14C standard purchased from Amersham Biosciences
were used to determine the molar concentration of 14CO2 incorporated
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into product. We also used a molar extinction coefficient of 1520 to
calculate the concentration of the substrate (27).
For substrate excess studies, 1500 nM FIXproGla41 and 25 nM active
carboxylase were pre-incubated in buffer A at 17 °C for 1 h, and the
assay was performed as described above for the enzyme excess experi-
ments. The turnover rate constant of FIXproGla41 molecule during the
steady state was determined by dividing the 14CO2 incorporation rate
during the post-burst, slower linear part of the curve in Fig. 2b by 305.6,
the y intercept of the steady state curve in Fig. 2b. This burst
size represents the concentration of 14CO2 incorporated into 25 nM
FIXproGla41 in one round of reaction (10). The kinetic studies of
FLEEL, EEL, and t-butoxycarbonyl-Glu-t-butyl ester carboxylation
were performed in buffer A using 25 nM active carboxylase at 17 °C for
30 min as described previously (23, 26).
Dissociation Rate Measurement—We measured the time course of
fluorescein-labeled peptide release from carboxylase as described pre-
viously (23, 26). We pre-incubated 20 nM fluorescein-labeled peptide
with 100 nM carboxylase in buffer A at 17 °C for 1 h to allow the mixture
to come to equilibrium and then added a 200-fold excess of unlabeled
peptide (4 M) at time 0. To determine the effects of Glu-containing
substrates on the dissociation rate of f-proFIX18, 4.8 mM FLEEL or 250
M FIXGla1–46 were pre-incubated with 20 nM fluorescein-labeled
peptide and 100 nM carboxylase in buffer A. We took anisotropy meas-
urements at 20-s intervals and calculated the fraction bound of fluores-
cein-labeled peptide at each data point as described previously. We
conducted all off-rate experiments at 17 °C and determined the rate
constants as described previously (26).
Measurement of the Induced Fluorescence Intensity Changes of the
Carboxylase-bound, Fluorescein-labeled ProFIX18 by FLEEL—For
each sample, 10 nM fluorescein-labeled proFIX18 and 350 nM carboxyl-
ase were pre-incubated with a desired concentration of FLEEL, or
FLDDL in buffer A at 10 °C for 1 h. In addition to the FDDL control, a
second control included heat-inactivated carboxylase instead of active
enzyme. The fluorescence intensity of carboxylase bound fluorescein-
labeled proFIX18 was determined as described previously (23).
RESULTS
Kd Values of ProFIX18, FIXProGla41, and Fully Carboxyl-
ated FIXProGla41 for Carboxylase—The contribution of the
Gla domain to the affinity of the substrate was determined by
measuring the changes in anisotropy caused by adding increas-
ing concentrations of carboxylase to fixed concentrations of
f-proFIX18, f-FIXproGla41, or f-carboxylated FIXproGla41.
The Kd values at 17 °C are 50.0  1.7 nM for f-proFIX18, 2.5 
0.1 nM for f-FIXproGla41, and 19.7  2.0 nM for f-carboxylated
FIXproGla41 (Fig. 1).
Kinetics of FIXproGla41 Carboxylation with Enzyme in Ex-
cess of Substrate—The time course for carboxylation of FIXpro-
Gla41 in the presence of excess carboxylase appears in Fig. 2a.
The conditions of the experiments ensure that more than 99%
of the substrate is bound to the carboxylase at the beginning of
the reaction. There was no appreciable dissociation and re-
association during the reaction because control experiments
that included 800 nM proFIX18, a competitive inhibitor of FIX-
proGla41 carboxylation with a Kd 50 nM, added at time 0 did
not significantly affect carboxylation of carboxylase-bound FIX-
proGla41 (Fig. 2a). The observed carboxylation rate constant
for CO2 incorporation, determined from the linear portion of
the curve in Fig. 2a, is 0.020  0.003 s1. In addition, at the
completion of the reaction, the amount of radioactivity incor-
porated corresponds to 11.5 of the 12 Glu residues being
carboxylated.
Kinetics of FIXproGla41 Carboxylation with Substrate Ex-
cess Over Enzyme—Fig. 2b shows that the time course of car-
boxylation of 1500 nM FIXproGla41 by 25 nM carboxylase con-
sists of a burst phase followed by a long steady state rate. The
burst phase represents the accumulation of enzyme-product
complex during the carboxylation of the first 12 glutamic acid
residues. The rate determined from the burst phase of Fig. 2b,
0.016 s1, agrees, as it should, with the value (0.02 s1) deter-
mined from the enzyme excess experiments Fig. 2a. The agree-
ment of these two values testifies to their accuracy. In addition,
the y intercept of the slower steady state phase is 305 nM which,
when divided by the number of Gla residues modified during
one round of carboxylation, 12, estimates that the concentra-
tion of active enzyme is 25.4 nM. We estimated that our enzyme
concentration was 25 nM by titration with a tight binding
propeptide (23). Again, the agreement between these two val-
ues emphasizes the accuracy of our method for determining the
concentration of active enzyme.
The slower linear rate shown in Fig. 2b depicts the steady
state rate of FIXproGla41 carboxylation. The steady state rate
constant, 4.5  104 s1, was determined by dividing the slope
by the enzyme concentration and the number of Glu residues,
12, expected to be modified.
Koff Values for f-proFIX18, f-FIXproGla41, and Carboxylated
f-FIXproGla41—Because the balance between the rate of car-
boxylation and the rate of substrate release influences full
carboxylation, we measured the dissociation rates of these pep-
tides from carboxylase by using the same conditions that we
routinely use for determining in vitro rates of carboxylation.
Figs. 3 and 4 show that a single exponential decay curve sat-
isfactorily fits the time for dissociation of a carboxylase-sub-
strate complex, allowing us to determine the koff. The rate
constants for f-proFIX18, f-FIXproGla41, and carboxylated f-
FIXproGla41 are shown in Table I. It is significant that the rate
of dissociation (3.7  104 s1) is so similar to the steady state
rate constant (4.5  104 s1) measured above.
The Effects of Glutamic Acid-containing Peptides on the Dis-
sociation Rate of ProFIX18—It is known that binding of the
propeptide to the carboxylase reduces the Km of a small sub-
strate (FLEEL) (26, 28, 29). Moreover, under turnover condi-
tions (in the presence of FLEEL, vitamin K, CO2, and O2), both
the Kd and the koff values of proFIX18 decrease relative to those
in the absence of substrates (23). This indicates that occupancy
of sites other than the propeptide site stabilizes the enzyme-
propeptide complex. This effect could be because of Glu binding
to the active site, binding of vitamin K, CO2, or O2, or a
combination of all of these. To assess the effects of glutamate-
containing substrates alone on the affinity of proFIX18 for
carboxylase, we measured the koff of proFIX18 in the presence
FIG. 1. Determination of the affinities of fluorescently labeled
proFIX18, FIXproGla41, or carboxylated FIXproGla41. The points
represent samples containing varying concentrations of purified car-
boxylase and 10 nM proFIX18 (triangle), 10 nM FIXproGla41 (circle), or
10 nM carboxylated FIXproGla41 (squares). The concentration of pep-
tide bound was calculated from fluorescence anisotropy changes. The Kd
values were obtained by fitting the titration data to the appro-
priate quadratic equation. The Kd values of carboxylase for proFIX18,
FIXproGla41, and carboxylated FIXproGla41 were 50  1.7, 2.5  0.1,
and 19.7  2.0 nM, respectively. The inset represents the full titration
curve of proFIX18 against carboxylase.
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of FLEEL or the entire Gla domain (FIXGla1–46). As shown in
Table I, the off-rate constant of proFIX18 in the presence of
FLEEL is decreased 3-fold, whereas FIXGla1–46 decreases the
rate of dissociation 9-fold. Addition of reduced vitamin K or
CO2 had no effect on the dissociation rate.
The Effect of FLEEL on the Fluorescence Intensity of Carbox-
ylase-bound Fluorescein-labeled Propeptide—Fluorescence in-
tensity is sensitive to its local environment. Hence, any confor-
mational change, accompanied by a change in environment at
the propeptide-binding site, may affect the intensity of a fluo-
rescein-labeled proFIX18 bound to carboxylase. The concentra-
tion of FLEEL required for half-maximal intensity change is
0.62 mM (Fig. 5); this is similar to the Km of carboxylase for
FLEEL (0.8 mM in this study) in the presence of propeptide. In
contrast, FLDDL induced no intensity change, indicating the
importance of Glu residues for the allosteric effect.
DISCUSSION
The purpose of this study was to further understand the
mechanism of the processive carboxylation of factor IX. We
have proposed that the degree of carboxylation is controlled by
the balance between the dissociation rate of the product and
the rate of carboxylation of the substrate (30). This hypothesis
was based upon our measurements of the koff values of propep-
tides (23) from the carboxylase and on our rationale that the
rate of carboxylation of a propeptide-containing substrate,
FIXproGla41, would be at least as fast, and probably faster,
than that of FLEEL because we expected the concentration of
Glu in a bound substrate would be much higher than the
non-tethered FLEEL. Thus, we were surprised to find that the
apparent average rate constant for carboxylation of a FIXpro-
Gla41 substrate during one binding event was about one-four-
teenth that of the FLEEL carboxylation rate (Table II) The rate
constants for FIXproGla41 were determined both in enzyme
excess where the concentration of the substrate is required to
determine the rate constant and in substrate excess where the
concentration of enzyme is required.
There are three important pieces of information that can be
derived from the substrate excess data. First, we can measure
the carboxylation rate constant from the linear burst phase and
determine the average carboxylation rate of the factor IX Gla
domain while it is tethered to the carboxylase by the propeptide
of FIX; this rate, 0.016 s1, agrees very well with the rate
determined in enzyme excess (0.02 s1). Second, from the
slower linear portion of the curve, we can determine the steady
state turnover rate; this rate agrees very well with the koff
value of the fully carboxylated product calculated from anisot-
ropy. Third, we can estimate the enzyme concentration from
the y intercept of the steady state rate. The y intercept varied
from about 287 to 305 nM depending upon which points were
chosen for drawing the line. When divided by the number of
expected Gla residues, 12, the enzyme concentration was cal-
culated to be between 23 and 25 nM. A Dynafit model of the
data predicted a value of 27 nM for the enzyme. According to our
titration with a consensus propeptide, the concentration of
enzyme in the substrate excess experiments was estimated to
be 25 nM, so the agreement is very good.
We also measured the rate constant for the carboxylation of
FIXproGla41 with enzyme in excess over substrate; in this case
FIG. 2. The time course of carboxylation of the pre-formed
carboxylase-FIXproGla41 complex at 17 °C. a, reactions in the
absence of proFIX18 (filled circles) and in the presence of 800 nM
proFIX18 (triangles) were performed as described under “Experimental
Procedures.” Each reaction contained 250 nM active carboxylase and 50
nM FIXproGla41. The line represents the linear regression of the first
four points. b, carboxylation time course with FIXproGla41 in excess of
carboxylase. Reactions were performed using 25 nM purified carboxyl-
ase and 1500 nM FIXproGla41 at 17 °C as described under “Experimen-
tal Procedures.” The slow linear part represents the steady state of
FIXproGla41 carboxylation, and the straight line represents the linear
regression of the last five points. The fast linear part is the burst phase
that is determined from the first 10 min of reaction. Points represent
the average of three independent experiments.
FIG. 3. Dissociation time course from carboxylase of f-FIXpro-
Gla41 (circles) and carboxylated f-FIXproGla41 (triangles). Ex-
periments were done at 17 °C using 20 nM f-peptide and 100 nM car-
boxylase as described under “Experimental Procedures.” 4 M
unlabeled peptide was used at time 0 to minimize the re-association of
f-peptide to carboxylase. Rate constants were determined by fitting
data to the equation for single exponential decay.
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the rate is dependent only upon the substrate concentration
because all of the substrate is bound to the carboxylase. In the
enzyme excess experiments, the rate constant measured from
the linear portion of the curve was 0.02 s1. The excellent
agreement with the calculation from the substrate excess ex-
periments discussed above (0.016 s1) suggests that for the
conditions and substrates used in our experiments the calcu-
lated rate is reasonably accurate. Our experiments in enzyme
excess (Fig. 2a) make several additional important points re-
garding the observed carboxylation rate of a propeptide-con-
taining substrate. Within experimental error, the rate of car-
boxylation is linear up to about 85% completion. This suggests
that for the first 10 carboxylations, the effective concentration
of Glu does not change because the observed rate remains the
same, whereas the actual concentration of Glu decreases. In
agreement with Stenina et al. (9), this indicates the enzyme
distinguishes between Glu and Gla and binds Glu preferen-
tially, i.e. Gla does not compete with Glu for the active site. The
linearity also suggests that the individual carboxylation rates
for the first 10 of the 12 Glu residues in the Gla domain of the
FIX are approximately the same and are controlled by the same
slow rate-limiting step. The observation that the last two Gla
residues are added slowly may be related to the observation
that factor IX produced in cell culture has a significant amount
of FIX lacking the Gla modifications at Glu36 and Glu40 (31).
The affinity of the propeptide of FIX is in the nanomolar range,
and a complex with this high affinity is expected to be rela-
tively rigid. If true, this expectation means that the multiple
carboxylations must occur either by diffusion of the appropriate
Glu residues of the substrate into the active site or by move-
ment of the active site relative to the substrate. Therefore,
releasing Gla from the active site or rearranging the conforma-
tion of the Gla domain or the movement of the carboxylase
active site after each carboxylation may control the observed
carboxylation rate of FIXproGla41 rendering the rate of car-
boxylation of the propeptide-bound Gla domain slower than the
rate of FLEEL carboxylation.
In the only other study using concentrations that approxi-
mate single turnover, Stenina et al. (9) reported that the rates
of carboxylation for profactor IX and that of the small substrate
EEL are similar. The kcat value they report for EEL was about
FIG. 4. The effects of Glu-containing peptides on the dissociation rate of proFIX18. The faster decay curves (open circles) in a and b
represent the dissociation time course of proFIX18 in the absence of a Glu-containing peptide. The slower decay curves (closed circles) represent
the dissociation of proFIX18 from carboxylase in the presence of 4.8 mM FLEEL (a) or 250 M FIXGla1–46 (b). Experiments were performed as
described in the legend of Fig. 3.
TABLE I
The koff values of propeptide-containing substrates from carboxylase
Each koff represents the average of results from three independent
measurements.
Fluorescein-labeled peptide Glu-containing peptide koff (10
5 s1)




f-pro FIX18 273  9
f-pro FIX18 4.8 mM FLEEL 90  5
f-pro FIX18 250 M FIXGla 1–46 31  4
FIG. 5. The effect of FLEEL on the fluorescence intensity of the
carboxylase-bound fluorescein-labeled proFIX18. The intensity
changes induced by small peptides were determined by measuring the
fluorescence intensity of 10 nM fluorescein-labeled proFIX18 that was
incubated with 350 nM active carboxylase at varying concentrations of
FLEEL (filled circles) or FLDDL (filled triangles). In a control experi-
ment, 350 nM heat-inactivated carboxylase was incubated with varying
concentrations of FLEEL and 10 nM fluorescein-labeled proFIX18 (open
triangles). The excitation wavelength is 490 mm and the emission
wavelength is 525 mm. The curve represents the hyperbolic regression
of filled circles.
TABLE II
The kinetic properties of EEL, FLEEL and FIXproGla41 carboxylation
Substrate Km kcat
M s1
Boc-Glu-OtBua 3450  425 0.08  0.01
EELa 328  23 0.21  0.03
FLEELa 804  39 0.28  0.07
FIXproGla41b 0.020  0.004
a Determined in the presence of 5 M proFIX18. OtBu is t-butyl ester.
b 14CO2 incorporation rate constant during a single binding event,
determined from the experiments with enzyme in excess (Fig. 2).
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4-fold slower than our value for FLEEL. When we used their
conditions and studied EEL kinetics, we obtained results sim-
ilar to theirs. However, no matter whether we use their rate
constants or ours to predict the extent of carboxylation, the rate
is still too slow to result in full carboxylation, if the substrate
dissociation rate is dependent solely on the affinity of the
propeptide.
Our rate constant measurements for a tethered substrate
suggest that, for complete carboxylation to occur, factors other
than the propeptide must contribute to substrate binding.
Therefore, we measured the Kd and koff values for FIXproGla41
and fully carboxylated FIXproGla41. We found that the Kd
value of FIXproGla41 for carboxylase was 20-fold lower than
that of proFIX18, and that the koff value for proFIX18 was
30-fold faster than that of FIXproGla41. This indicates that the
Gla domain of factor IX contributes significantly to the inter-
action between profactor IX and the carboxylase. The impor-
tance of these measurements to our proposed mechanism is
that the koff of FIXproGla41 is about 220-fold slower than the
rate constant of carboxylation. This slow dissociation rate
should ensure nearly full carboxylation because 95% of the
substrate should still be associated with the carboxylase 10
min after binding, and carboxylation is nearly complete in 10
min (Fig. 2a).
A further important point derived from our measurements of
the koff for carboxylated FIXproGla41 is that its koff (3.7  10
4
s1) is nearly identical with the steady state rate of carboxyl-
ation (4.5  104 s1) measured in the substrate excess exper-
iment; this means that the overall rate of carboxylation is
determined by the release of the product. A further point is that
while the koff of carboxylated FIXproGla41 is 4-fold faster than
that of FIXproGla41, the difference in Kd is 8-fold. This sug-
gests that the association rate constant of the product is slower
than that of the substrate.
The effect of the Gla domain on propeptide binding is pri-
marily the result of its allosteric effect on the propeptide-
binding site; the addition of 250 M FIXGla1–46 causes a 9-fold
decrease in koff. The true allosteric effect is probably greater
because the solubility of the FIXGla1–46 limits its achievable
concentration to two times higher than its Km. Even so, the 3-
fold difference in koff between proFIX18 in the presence of the
Gla domain and FIXproGla41 indicates that a major part of
the effect of the Gla domain on propeptide binding is allosteric.
We demonstrated previously that, under turnover condi-
tions, the affinity or the propeptide for the carboxylase was
increased (23). In this work we demonstrate that the effect is
due to FLEEL and not to another component of the reaction
mix such as vitamin K. Control experiments with FLDDL have
no measurable effect on propeptide koff. In addition FLEEL, but
not FLDDL, caused a fluorescence intensity change of a fluo-
rescein-labeled propeptide bound to the carboxylase. This sug-
gests that FLEEL induces a conformational change at the
propeptide-binding site, thus stabilizing the carboxylase-
propeptide complex.
The effect of FLEEL on propeptide binding strongly suggests
that occupancy of the active site by glutamic acid is critical for
the allosteric effect observed when the substrate binds to the
enzyme. The importance of Glu at the active site is further
emphasized by the 4-fold increase in the koff of fully carbox-
ylated FIXproGla41 compared with FIXproGla41. It is worth
emphasizing that the binding of FLEEL to the active site
results in a 3-fold decrease in the off rate of the propeptide from
the carboxylase, whereas the koff of fully carboxylated FIXpro-
Gla41 is 4-fold faster than its uncarboxylated counterpart. In
both cases, the difference appears to be the presence or absence
of Glu. The lower affinity, although the difference is modest, of
the carboxylated form relative to the uncarboxylated form of
FIXproGla41 suggests that the change in dissociation rate that
accompanies complete carboxylation contributes to product
release.
Hallgren et al. (32) proposed an active release mechanism
based upon their observation that, in a chase experiment, the
amount of carboxylated factor IX-carboxylase complex remains
unchanged unless a competing propeptide is present. They
concluded that another propeptide binds to a second propep-
tide-binding site, facilitating the release of the carboxylated
proFIX. However, in their experiments, the concentrations of
substrate and carboxylase were approximately equal and,
given the affinity of the propeptide of FIX for the carboxylase,
any dissociated product would have re-associated unless a com-
petitive substrate was present. Furthermore, our estimate of
the stoichiometry of propeptide to carboxylase is 1:1 (23). Our
observation that the steady state turnover rate of FIXproGla41
is nearly identical to the dissociation rate of the carboxylated
product in the absence of other substrates or cofactors suggests
that the rate-limiting step of carboxylation relies on the affinity
of the enzyme-product complex; thus, there is no reason to
increase the complexity of the models by invoking a second
propeptide-binding site.
In this study, we report for the first time the Kd value of
carboxylase for a peptide containing both the propeptide and
Gla domain of factor IX, and we show that the Gla domain
significantly alters the affinity of the substrate for the enzyme.
We also determined the koff and the carboxylation rate constant
of a propeptide-containing substrate in vitro. Our results indi-
cate that the primary contribution of the Gla domain to binding
is an allosteric effect on propeptide binding and that this effect
is potentially important for processive carboxylation of factor
IX. Our results additionally show that product release is the
rate-limiting step in profactor IX carboxylation. We do not
know to what extent this allosteric effect contributes to the
interaction of other vitamin K-dependent proteins with carbox-
ylase. Do the Gla domains of those vitamin K-dependent pro-
teins whose propeptides have lower apparent affinities for car-
boxylase than proFIX have different affinities for the
carboxylase? Will propeptides with very high affinity be mod-
ulated by their Gla domains? Have individual Gla domains
evolved to work best with their own propeptides? Further stud-
ies to discover how the Gla domain interacts with carboxylase
and how it repositions the new Glu residues to the carboxylase
active site will contribute to understanding the processive
mechanism of carboxylase.
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